HBM Holdings Limited (2142.HK)
HKD 1.28
(4.92%)
HKD 1.28
(4.92%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 66.01 Million USD | -27.4% |
| 2022 | 90.92 Million USD | 366.95% |
| 2021 | 19.47 Million USD | 1028.87% |
| 2020 | 1.72 Million USD | -9.59% |
| 2019 | 1.9 Million USD | -39.29% |
| 2018 | 3.14 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 64.95 Million USD | 1.89% |
| 2024 Q1 | 64.95 Million USD | -1.6% |
| 2023 Q2 | 83.04 Million USD | 1.22% |
| 2023 Q1 | 82.04 Million USD | -9.77% |
| 2023 Q4 | 66.01 Million USD | 1.34% |
| 2023 FY | 66.01 Million USD | -27.4% |
| 2023 Q3 | 65.13 Million USD | -21.56% |
| 2022 Q2 | 61.76 Million USD | 4.37% |
| 2022 FY | 90.92 Million USD | 366.95% |
| 2022 Q4 | 90.92 Million USD | 1.45% |
| 2022 Q3 | 89.63 Million USD | 45.13% |
| 2022 Q1 | 59.17 Million USD | 203.89% |
| 2021 Q4 | 19.47 Million USD | 15.37% |
| 2021 Q1 | 3.48 Million USD | 101.8% |
| 2021 Q2 | 5.32 Million USD | 52.89% |
| 2021 Q3 | 16.87 Million USD | 217.16% |
| 2021 FY | 19.47 Million USD | 1028.87% |
| 2020 FY | 1.72 Million USD | -9.59% |
| 2020 Q4 | 1.72 Million USD | 520.5% |
| 2020 Q3 | 278 Thousand USD | -86.33% |
| 2020 Q2 | 2.03 Million USD | -99.35% |
| 2020 Q1 | 312 Million USD | 16252.52% |
| 2019 Q1 | - USD | 0.0% |
| 2019 Q3 | 203.03 Million USD | 0.0% |
| 2019 Q4 | 1.9 Million USD | -99.06% |
| 2019 FY | 1.9 Million USD | -39.29% |
| 2018 FY | 3.14 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 52.86 Million HKD | -24.864% |
| CK Life Sciences Int'l., (Holdings) Inc. | 5.93 Billion HKD | 98.887% |